StockData
Centene Corp logo

Centene Corp (CNC) stock

CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/307% above fair value
$72.55−2.22 (-2.97%)

Close on Nov 17, 2026Market cap $35.92BP/E 24.8Yield –

Centene operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Centene's operating income for the twelve months ending Sep 30, 2026 was $1.01B. For fiscal 2025 it was -$7.62B, down 340.1% from the year before. The highest annual figure on record is $3.18B in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.62B-340.1%
FY2024Dec 31, 2024$3.18B+8.4%
FY2023Dec 31, 2023$2.93B+122.3%
FY2022Dec 31, 2022$1.32B-26.1%
FY2021Dec 31, 2021$1.78B-42.1%
FY2020Dec 31, 2020$3.08B+73.0%
FY2019Dec 31, 2019$1.78B+22.2%
FY2018Dec 31, 2018$1.46B+21.6%
FY2017Dec 31, 2017$1.20B-5.1%
FY2016Dec 31, 2016$1.26B+79.1%
FY2015Dec 31, 2015$705.00M+51.9%
FY2014Dec 31, 2014$464.00M+67.5%
FY2013Dec 31, 2013$277.00M+156.5%
FY2012Dec 31, 2012$108.00M-47.0%
FY2011Dec 31, 2011$203.80M+29.8%
FY2010Dec 31, 2010$157.07M+13.7%
FY2009Dec 31, 2009$138.14M+5.0%
FY2008Dec 31, 2008$131.56M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$307.00M–
Q2 FY2026Jun 30, 2026$1.20B–
Q1 FY2026Mar 31, 2026$1.86B+21.3%
Q4 FY2025Dec 31, 2025-$1.75B-1097.1%
Q3 FY2025Sep 30, 2025-$6.95B-1145.7%
Q2 FY2025Jun 30, 2025-$458.00M-137.3%
Q1 FY2025Mar 31, 2025$1.53B+38.7%
Q4 FY2024Dec 31, 2024$175.00M–
Q3 FY2024Sep 30, 2024$665.00M-9.5%
Q2 FY2024Jun 30, 2024$1.23B+5.0%
Q1 FY2024Mar 31, 2024$1.11B-9.2%
Q4 FY2023Dec 31, 2023-$194.00M–
Q3 FY2023Sep 30, 2023$735.00M+54.4%
Q2 FY2023Jun 30, 2023$1.17B–
Q1 FY2023Mar 31, 2023$1.22B-2.8%
Q4 FY2022Dec 31, 2022-$282.00M-146.8%
Q3 FY2022Sep 30, 2022$476.00M-12.7%
Q2 FY2022Jun 30, 2022-$129.00M–
Q1 FY2022Mar 31, 2022$1.25B+18.9%
Q4 FY2021Dec 31, 2021$603.00M+3920.0%
Q3 FY2021Sep 30, 2021$545.00M-36.7%
Q2 FY2021Jun 30, 2021-$418.00M-120.7%
Q1 FY2021Mar 31, 2021$1.05B+460.6%
Q4 FY2020Dec 31, 2020$15.00M-94.6%
Q3 FY2020Sep 30, 2020$861.00M+389.2%
Q2 FY2020Jun 30, 2020$2.02B+213.8%
Q1 FY2020Mar 31, 2020$188.00M-72.6%
Q4 FY2019Dec 31, 2019$277.00M-28.6%
Q3 FY2019Sep 30, 2019$176.00M+329.3%
Q2 FY2019Jun 30, 2019$643.00M+31.5%
Q1 FY2019Mar 31, 2019$685.00M+26.9%
Q4 FY2018Dec 31, 2018$388.00M+114.4%
Q3 FY2018Sep 30, 2018$41.00M-87.9%
Q2 FY2018Jun 30, 2018$489.00M+11.6%
Q1 FY2018Mar 31, 2018$540.00M+125.0%
Q4 FY2017Dec 31, 2017$181.00M-65.5%
Q3 FY2017Sep 30, 2017$340.00M–
Q2 FY2017Jun 30, 2017$438.00M–
Q1 FY2017Mar 31, 2017$240.00M–
Q4 FY2016Dec 31, 2016$524.00M–

More Centene figures

See a number that looks wrong?